Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2015 Jun 30;8(9):864–872. doi: 10.1158/1940-6207.CAPR-15-0029

Figure 3.

Figure 3

Change in AFP by site and treatment arm. Serum AFP increased between Week 0 and Week 24 among subjects randomized to placebo (control) at all sites. At four of the five sites, serum AFP decreased among subjects randomized to SAMe. However, AFP did not decrease among subjects receiving SAMe at the site with the largest number of subjects enrolled (LBVA).